Author

Martina Tomberger

Center For Biomarker Research In Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Assay:spatial transcriptomics· 2 Approach:statistical model· 2 Approach:deep learning· 1

Frequent Co-Authors

Lukas KenneriD· 3 shared Karolína TrachtováiD· 2 shared Alessandro Lieblich· 1 shared Anne KrogsdamiD· 1 shared Armin FrilleiD· 1 shared Barbara Katharina GeistiD· 1 shared Bernhard SattleriD· 1 shared Boris TichýiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Lukas KennerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 13, 2026

Amygdala metabolic activity on FDG PET is associated with survival, response to immune checkpoint inhibition, and tumor immune signaling in non-small cell lung cancer

Barbara Katharina Geist, Chrysoula Vraka, Clara T.S. Mertel…·Marcus Hacker

DOI 10.64898/2026.09.10.750685

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedOct 31, 2024

Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment

Christina Sternberg, Martin Raigel, Tanja Limberger…·Lukas Kenner

This study shows that activating GP130 in prostate epithelial cells suppresses tumor growth through senescence and immune activation, suggesting a new therapeutic approach.

17 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 21, 2024

Conventional therapy induces tumor immunoediting and modulates the immune contexture in colorectal cancer

Georgios Fotakis, Dietmar Rieder, Zuzana Loncová…·Zlatko Trajanoski

This study shows conventional therapy in CRC induces immunoediting and changes immune contexture, with AI identifying mucin deposits as a potential surrogate marker.

DOI 10.1101/2024.08.21.608938

humanbulk RNA-seq

𝕏 PostBluesky